Osimertinib-associated ashy dermatosis–like hyperpigmentation

JAAD Case Reports

Pawinee Rerknimitr, MD, MSc¹  Pattamon Lertpichitkul, MD²  Pravit Asawanonda, MD, DSc²  Jade Wititsuwannakul, MD² 

[1] Correspondence to: Pawinee Rerknimitr, MD, MSc, Division of Dermatology, Department of Medicine, Faculty of Medicine, Skin and Allergy Research Unit, Chulalongkorn University, 1873 Rama IV Rd, Pathumwan, Bangkok 10330, Thailand.;Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Skin and Allergy Research Unit, Chulalongkorn University, Bangkok, Thailand;

关键词: ashy;    epidermal growth factor receptor inhibitor;    hyperpigmentation;    osimertinib;    rash;   

DOI  :  

来源: DOAJ

【 授权许可】

Unknown